SRF Limited — Important, 20-01-2026: Capacity addition
20-01-2026 | 03:36 pm
20-01-2026 | 03:36 pm
SRF Board approved a Rs. 180 Cr Pharma Intermediate Plant (PIP-2) at Dahej. This expansion targets new pharma business opportunities and is expected to be operational by Q2 FY27, funded by debt and internal accruals.
No comments yet. Be the first to comment!
